217 Users Online
Pharmaceutical Excipients For Taste Masking Market by Excipient (Natural, Artificial, Nutritive, Non- nutritive and Polyols)
The Global revenue from the Pharmaceutical Excipients for Taste Masking Market was about US$ 877.4 Million in 2022, with the global market expected to grow at a CAGR of 4.8% to reach a valuation of around US$ 1.5 Billion by the end of 2033.
|
Market Size (2023) |
US$ 924.0 Million |
|
Projected Market Value (2033) |
US$ 1.5 Billion |
|
Global Market Growth Rate (2023 to 2033) |
4.8% CAGR |
|
Market Share of Top 5 Countries |
58.8% |
As assessed by Persistence Market Research, artificial masking agents held a market share of around 34.6% in the global market, in 2022. Overall, pharmaceutical excipients for taste masking market sales account for approximately 14.6% of revenue share in the global excipient market, which was valued at around US$ 6.0 Billion in 2022.
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global market recorded a historic CAGR of 4.2% in the last 7 years between 2015 and 2022.
To cover up the bitter or unpleasant taste of medications' active medicinal components, taste-masking procedures are used. It might be difficult to provide oral medications to geriatric and paediatric patient populations. Formulation technology and taste masking go hand in hand and should be compatible with one another. Medications like antibiotics, anti-inflammatory medications, and analgesics frequently use taste masking.
Over the years, approaches to using medicinal excipients for flavour masking have changed. Early in the 1990s, sweeteners were frequently used. However, employing sweeteners alone makes it difficult to hide the taste of water-soluble medications that are administered in high amounts.
Later, coating as a taste-mapping method gained acceptance, and numerous patents were granted for the coating method in pharmaceutical excipients for taste-mapping. Granulation has been more popular during the past few years. In the years to come, the market for pharmaceutical excipients for taste masking is expected to grow as a result of such technological advancements.
The global market is likely to show high growth over the coming years at a CAGR of 4.8% and reach a global market size of US$ 1.5 Billion by 2033.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version“Increasing Demand for Medicines”
Any substance's flavour can be distinguished by its taste and odour. Any substance with a bitter taste finds it challenging to gain widespread acceptance. Thus, in order for patients such as elderly people and children, to take typical bitter medications orally, taste masking chemicals are now required.
Pharmaceutical excipients for taste masking play a crucial part in the final dosage of oral medications, unless the substances have no taste or have a bad taste. Pharmaceutical excipients for flavour masking help give many final medicine formulations a pleasing taste, potentially removing nausea brought on by drug taste.
The usage of various excipients for sweetening, range from synthetic to natural, has offered producers the viability they need to compete in the pharmaceutical excipients for flavour masking market in terms of price, availability, and accessibility.
Chronic and lifestyle diseases are becoming more and more common everywhere in the world. For society's health, the prevalence of chronic diseases is a significant burden. Diabetes, cardiovascular conditions, cancer, obesity, osteoporosis, and pulmonary conditions are examples of major chronic diseases. Lifestyle choices like smoking, not exercising, and eating unhealthy foods all contribute to an increase in medicine demand, which eventually leads to a market expansion for pharmaceutical excipients that conceal flavour.
“Increasing Regulatory Stringency for Drug and Excipient Approval.”
The procedures for approving generic drugs are essentially the same everywhere, with minor variations in undeveloped countries. This is due to the fact the world is not obliged to complete a bioequivalence (BE) research in order to receive generic medicine approval. Medical professionals assert that governments must guarantee the uniform quality of all generic medications. Only then can physicians be content and confident in writing generic medicine prescriptions.
Physicians' (and even patients') lack of trust in generic drugs has been largely attributed to weak regulatory standards governing the number of generic drugs and the number of permitted contaminant.
Controlling the manufacturing and distribution of excipients is now a priority for authorities and medication manufacturers because combining excipients has resulted in adverse patient outcomes. The development of new excipients and delivery technologies has also increased the importance of greater control over the supply and quality of pharmaceutical excipients in the context of in vivo activity.
Excipient suppliers must satisfy the pharmaceutical industry's quality standards due to the excipients' crucial role in pharmaceutical dosage forms, and the pharmaceutical industry as a whole must work to ensure the product's safety. The supply chain's use or storage integrity. Therefore, it is anticipated that the expansion of the worldwide market will be constrained by the increasing regulatory requirements for the licensing of pharmaceuticals and excipients.
Sales Team
Client Partner
Why is the United States Market Booming?
“Introduction of New Products”
The United States accounted for around 91.3% market share in the North America market in 2022. The rapidly expanding pharmaceutical sector, rising demand for functional excipients, the existence of significant competitors in the market, and technological improvements will all significantly contribute to the market's growth over the forecast period.
The introduction of technologically improved or superior excipients also accelerates the market's growth.
Problems with solubility that can't be resolved by excipients or manufacturing techniques already in use are eliminated by this method.
Will Germany Be a Lucrative Market for Pharmaceutical Excipients for Taste Masking?
“Growth in Demand Owed to Rising Patient Population”
Germany market held around 26.3% market share of the Europe market in 2022.
The factors contributing to regional domination include the rising prevalence of chronic diseases brought on by sedentary lifestyles, significant investments by pharmaceutical corporations in the production of medicines, and the adoption of emerging technologies like nanotechnology.
Companies in the industry would benefit financially from employing effective expansion tactics and beginning the development of new products.
How is China Emerging as a Prominent Market?
“Implementation of Taste Masking Agents in TCM”
China held a market share of about 69.7% of the East Asia market in 2022. The taste-making mechanism of chitosan on bitter alkaloid and flavonoid glycoside drugs was implemented on traditional Chinese medicine. The bad taste of TCMs can likewise be improved with this taste-masking method.
The flavor-masking method may offer fresh insight into how to mask the taste of TCMs, particularly for some TCM oral solutions for children, which will significantly increase pediatric patients' compliance.
Which Excipient is Driving Demand within the Global Market?
“Significant Advances for Masking Taste of API”
The artificial excipient held around 34.6% share of the total market in 2022. An efficient oral dose form must include bitterness reduction and inhibition. Much progress has been achieved in the development of taste-masking compositions in recent years.
Synthetic excipients are used in the manufacturing of tablets to bind the tablet together, decrease die-wall resistance between both the tablets and the tableting press, manage pH balance, and enable the tablets to disintegrate in the stomach after consumption. This has fueled the segment's expansion.
Which Technique is Driving Demand within the Global Market?
“Extended Product Life”
The coating technique held around 33.1 % share of the total market in 2022. Direct compression, dry granulation, film coating, hot melt extrusion, molecular encapsulation, spheronization, spray drying, and wet granulation, are some of the coating system methods.
Anti-corrosion coating are the primary factors driving the segment growth. Anti-corrosion coatings shield the product from pollutants and contaminants that shorten its lifespan. The technique helps increases product life (both aesthetically and functionally) and minimizes product or process contamination.
Which Usage of Pharmaceutical Excipients for Taste Masking Promotes Market Traction?
“Increasing Solubility Characteristics of Solid Dosage Form”
Solid dosage form held around 74.8% share of the total market in 2022. In aqueous settings, such as the luminal fluids of the digestive tract, many active pharmaceutical ingredients (APIs) have poor solubility and sluggish dissolution rates. These compounds often have very low oral bioavailability due to their weak solubility features.
Over the predicted period, this contributes to the segment's growth on a global scale.
Which End User Propels the Global Sales in the Market?
“Growing Advantages of Excipients”
The pharmaceutical segment held a share of about 66.9% in 2022, within the global market. Excipients used in pharmaceutical production help with stability, bioavailability, patient acceptance, and manufacturing. They can alter medication pharmacokinetics, stability, and absorption while assisting in overcoming the API's manufacturing constraints. Excipients are included in medicine formulations to enhance the flavor and look of the finished product while increasing the shelf life.
Throughout the predicted period, these factors support the pharmaceutical segment's growth.
In order to increase their market share, major players in the pharmaceutical excipients for taste masking market are concentrating on developing new platforms and a range of taste masking technologies. These include stimuli responsive drug delivery systems that use polymers that are pH- and ion-sensitive to hide the bitter taste of medicines.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the pharmaceutical excipients for taste masking market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2015 to 2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Excipient:
Technique:
Usage:
End-User:
Region:
The global market is currently valued at around US$ 877.4 Million in 2022.
The global market will be around US$ 924.0 Million in 2023
The global market is set to reach a valuation of around US$ 1.5 Billion by the end of 2033.
Sales of the market are set to witness growth at a CAGR of 4.8% between 2023 and 2033.
Demand for the global market increased at a 4.2% CAGR between 2015 and 2022.
The U.S., China, Germany, the U.K., and Japan account for most demand within the market, currently holding around 58.8% market share.
The U.S. accounts for around 91.3% share of the North American market in 2022.
The China market held a share of about 69.7% in the East Asia pharmaceutical excipients for taste masking market in 2022.
Germany market held around 26.3% market share of the Europe market in 2022.
Roquette Frères, Rochem International, Inc., Gattefose, Asahi Kasei Corporation, DuPont de Nemours, Inc., Dow Pharma Solutions, SPI Pharma, Inc., GPT Pharmaceuticals Pvt. Ltd., and Adare Pharmaceuticals Inc., are the key players within the global market.
